Production of lipospheres for bioactive compound delivery

Lipospheres in Drug Targets and Delivery: Approaches, Methods, and Applications

Volumn , Issue , 2004, Pages 23-40

  Esposito, Elisabetta ^a   Cortesi, Rita ^a   Nastruzzi, Claudio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953192427     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203505281     Document Type: Chapter

References (23)

1. Domb, A.J. et al., Degradable polymers for site-specific drug delivery, Polymer Adv. Technol., 3, 279, 1992.
2. Barke, S.A. and Khossravi, D., Drug delivery strategies for the new millennium, Drug Del. Technol., 6, 75, 2001.
3. Mizushima, Y., Lipid microspheres (lipid emulsions) as a drug carrier: an overview, Adv. Drug Del. Rev., 20, 113, 1996.
4. Ravi Kumar, M.N.V., Nano and microparticles as controlled drug delivery devices, J. Pharm. Pharmaceut. Sci., 3, 234, 2000.
5. Gombotz, W. et al., Prolonged release of GM-CSF, United States Patent: 5,942,253, 1995.
6. Wake, M.C. et al., Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro, Biomaterials, 19, 1255, 1998.
7. Cortesi, R. et al., Preparation of liposomes by reverse-phase evaporation using alternative organic solvents, J. Microencapsul., 16, 251, 1999.
8. Vyas, S.P., Singh, R. and Dimitrijevic, D., Development and characterization of nifedipine lipospheres, Pharmazie, 52, 403, 1997.
9. Jenning, V., Thünemann, A.F. and Gohla, S.H., Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids, Int. J. Pharm., 199, 167, 2000.
10. Schwarz, C. and Mehnert, W., Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization, J. Microencapsul., 16, 205, 1999.
11. Müller, R.H., Mäder, K. and Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art, Eur. J. Pharm. Biopharm., 50, 161, 2000.
12. Takenaga, M., Application of lipid microspheres for the treatment of cancer, Adv. Drug Del. Rev., 20, 209, 1996.
13. Yang, S.C., et al., Body distribution of camptothecin solid lipid nanoparticles after oral administration, Pharm. Res., 16, 751, 1999.
14. Inoue, K. et al., Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits, Arzneim-Forsch/Drug. Res., 45, 980, 1995.
15. Müller, R.H. et al., Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes, J. Control. Rel., 47, 261, 1997.
16. Schwarz, C. et al., Solid lipid nanoparticles (SLN) for controlled drug delivery: production, characterization and sterilization, J. Control. Rel., 30, 83, 1994.
17. Bodmeier, R., Chen, H. and Bhagwatwar, H., Polymer and wax microspheres prepared by emulsification techniques, Bull. Tech. Gattefossé, 1990, 83.
18. zur Mühlen, A., Schwarz, C. and Mehnert, W., Solid lipid nanoparticles (SLN) for controlled drug delivery: drug release and release mechanism, Eur. J. Pharm. Biopharm., 45, 149, 1998.
19. Arshady R., Albumin microspheres and microcapsules: methodology of manufacturing techniques. J. Control. Rel., 14, 111, 1990.
20. Cortesi, R. et al., Liposome-associated retinoids: production and antiproliferative activity on neoplastic cells, Eur. J. Pharm. Sci., 2, 281, 1994.
21. Pereira, G.R., Marchetti, J.M. and Bentley M.V., A rapid method for determination of progesterone by reversed-phase liquid chromatography from aqueous media, Anal. Lett., 33, 881, 2000.
22. Radulovic, D. et al., HPLC determination of sodium cromoglycate in pharmaceutical dosage forms, Farmaco, 49, 375, 1994.
23. Esposito, E. et al., Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: formulatory and drug release studies, J. Microencapsul., 14, 175, 1997.